Citigroup’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$279K Buy
3,722
+404
+12% +$33.1K ﹤0.01% 3838
2025
Q4
$259K Sell
3,318
-1,129
-25% -$91.6K ﹤0.01% 3876
2025
Q3
$378K Sell
4,447
-8,907
-67% -$714K ﹤0.01% 3711
2025
Q2
$1.04M Sell
13,354
-7,877
-37% -$581K ﹤0.01% 3170
2025
Q1
$1.54M Sell
21,231
-305
-1% -$25.6K ﹤0.01% 2936
2024
Q4
$1.91M Buy
21,536
+1,205
+6% +$107K ﹤0.01% 2858
2024
Q3
$1.72M Buy
20,331
+6,300
+45% +$559K ﹤0.01% 2796
2024
Q2
$1.3M Buy
14,031
+3,044
+28% +$308K ﹤0.01% 2709
2024
Q1
$1.24M Buy
10,987
+1,109
+11% +$111K ﹤0.01% 2855
2023
Q4
$920K Buy
9,878
+3,430
+53% +$302K ﹤0.01% 2890
2023
Q3
$591K Sell
6,448
-4,727
-42% -$508K ﹤0.01% 2937
2023
Q2
$1.36M Buy
11,175
+4,611
+70% +$497K ﹤0.01% 2578
2023
Q1
$643K Sell
6,564
-1,567
-19% -$150K ﹤0.01% 2929
2022
Q4
$659K Buy
8,131
+1,675
+26% +$141K ﹤0.01% 2973
2022
Q3
$490K Buy
6,456
+269
+4% +$25.9K ﹤0.01% 3247
2022
Q2
$675K Sell
6,187
-5,515
-47% -$586K ﹤0.01% 2994
2022
Q1
$1.16M Buy
11,702
+359
+3% +$34.2K ﹤0.01% 2817
2021
Q4
$1.08M Buy
11,343
+2,978
+36% +$299K ﹤0.01% 3165
2021
Q3
$926K Sell
8,365
-1,292
-13% -$147K ﹤0.01% 3147
2021
Q2
$1.12M Buy
9,657
+5,159
+115% +$593K ﹤0.01% 3130
2021
Q1
$468K Sell
4,498
-2,195
-33% -$273K ﹤0.01% 3503
2020
Q4
$805K Buy
6,693
+2,190
+49% +$221K ﹤0.01% 3759
2020
Q3
$391K Sell
4,503
-5,005
-53% -$431K ﹤0.01% 4067
2020
Q2
$771K Sell
9,508
-4,993
-34% -$364K ﹤0.01% 3827
2020
Q1
$1M Buy
14,501
+5,138
+55% +$542K ﹤0.01% 3175
2019
Q4
$1.07M Sell
9,363
-5,383
-37% -$670K ﹤0.01% 3679
2019
Q3
$1.93M Sell
14,746
-340
-2% -$44.3K ﹤0.01% 2910
2019
Q2
$1.85M Buy
15,086
+572
+4% +$65.7K ﹤0.01% 2951
2019
Q1
$1.52M Sell
14,514
-720
-5% -$77.4K ﹤0.01% 2957
2018
Q4
$1.56M Buy
15,234
+493
+3% +$54.7K ﹤0.01% 2924
2018
Q3
$1.75M Buy
14,741
+5,683
+63% +$642K ﹤0.01% 2887
2018
Q2
$869K Sell
9,058
-1,673
-16% -$155K ﹤0.01% 3509
2018
Q1
$873K Buy
10,731
+597
+6% +$46.3K ﹤0.01% 3385
2017
Q4
$732K Sell
10,134
-5,501
-35% -$375K ﹤0.01% 3673
2017
Q3
$961K Sell
15,635
-3,614
-19% -$220K ﹤0.01% 3420
2017
Q2
$1.16M Buy
19,249
+4,418
+30% +$282K ﹤0.01% 3152
2017
Q1
$969K Sell
14,831
-14,801
-50% -$1.05M ﹤0.01% 3253
2016
Q4
$2.08M Buy
29,632
+14,037
+90% +$893K ﹤0.01% 2897
2016
Q3
$977K Sell
15,595
-2,209
-12% -$136K ﹤0.01% 3248
2016
Q2
$1.07M Buy
17,804
+4,891
+38% +$268K ﹤0.01% 2890
2016
Q1
$642K Buy
12,913
+11,600
+883% +$577K ﹤0.01% 3848
2015
Q4
$70K Buy
1,313
+110
+9% +$5.51K ﹤0.01% 5669
2015
Q3
$54K Sell
1,203
-1,654
-58% -$82.5K ﹤0.01% 5390
2015
Q2
$156K Buy
2,857
+1,576
+123% +$78.1K ﹤0.01% 4643
2015
Q1
$61K Sell
1,281
-1,434
-53% -$61K ﹤0.01% 5424
2014
Q4
$114K Buy
2,715
+932
+52% +$36.7K ﹤0.01% 5144
2014
Q3
$63K Buy
1,783
+310
+21% +$11K ﹤0.01% 5130
2014
Q2
$50K Sell
1,473
-3,596
-71% -$116K ﹤0.01% 5178
2014
Q1
$174K Buy
5,069
+420
+9% +$13.9K ﹤0.01% 4477
2013
Q4
$164K Buy
4,649
+3,919
+537% +$128K ﹤0.01% 4834
2013
Q3
$22K Sell
730
-65
-8% -$1.92K ﹤0.01% 5864
2013
Q2
$22K Buy
+795
New +$21K ﹤0.01% 5793

Other funds holding USPH

Citigroup's USPH Position: Q1 2026 in Review

Citigroup increased its US Physical Therapy (USPH) stake by 12% in Q1 2026, buying an estimated $33.1K and bringing the position to 3,722 shares worth $279K. The position accounts for ﹤0.01% of the portfolio, ranked #3838.

Citigroup first reported a position in USPH in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.08M in Q4 2016. 229 funds tracked by Wall St. Rank hold USPH as of Q1 2026.

  • Citigroup held 3,722 shares of US Physical Therapy worth $279K as of Q1 2026.
  • Citigroup bought 404 US Physical Therapy shares in Q1 2026, an estimated $33.1K.
  • US Physical Therapy made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3838 holding.
  • Citigroup first reported a position in US Physical Therapy in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's US Physical Therapy position peaked at $2.08M in Q4 2016.
  • 229 funds tracked by Wall St. Rank held US Physical Therapy as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.